Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis

BACKGROUND: Metastatic melanoma patients can have durable responses to systemic therapy and even long-term survival. However, a large subgroup of patients does not benefit. Tumour metabolic alterations may well be involved in the efficacy of both targeted and immunotherapy. Knowledge on in vivo tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: de Heer, Ellen C., Brouwers, Adrienne H., Boellaard, Ronald, Sluiter, Wim J., Diercks, Gilles F. H., Hospers, Geke A. P., de Vries, Elisabeth G. E., Jalving, Mathilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246760/
https://www.ncbi.nlm.nih.gov/pubmed/30460579
http://dx.doi.org/10.1186/s13550-018-0453-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246760/
https://www.ncbi.nlm.nih.gov/pubmed/30460579
http://dx.doi.org/10.1186/s13550-018-0453-x

Ejemplares similares